Email a Friend
Print ArticleHypertension/High Blood Pressure Health Center
Blood Pressure Pill Exforge HCT Approved
May 5, 2009 -- The FDA has approved Exforge HCT, which combines three blood pressure drugs -- amlodipine, valsartan, and hydrochlorothiazide -- into one pill.
Amlodipine is a calcium-channel blocker. Valsartan is an angiotensin-receptor blocker (ARB). Hydrochlorothiazide is a diuretic.
In June 2007, the FDA approved Exforge, which contains amlodipine and valsartan. The newly approved Exforge HCT adds hydrochlorothiazide.
The FDA approved Exforge HCT based on a clinical trial that included more than 2,000 patients, according to a news release from Novartis, the drug company that makes Exforge and Exforge HCT.
Novartis plans to offer Exforge and Exforge HCT at the same price in the U.S.
del.icio.us
How Hypertension Affects Cardiac Risk
Jonathan Sackner Bernstein, MD, talks about high blood pressure and its effect on cardiac diseases
